Skip to content

Total debt at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$328K-59.1%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$2.38M+29.5%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$1.91M-44.3%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$83.16M-17.1%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$82.17M-6.5%
Alumis Inc. logo
Alumis Inc.ALMS
$35.66M+1,881%

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$923.31M+259%
Enterprise value$700.21M+179%
P/S159.6×+87.1×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $6.1M.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's total debt?
DBV Technologies (DBVT) reported total debt of $6.1M in Q1 2026.
How has DBV Technologies's total debt changed year-over-year?
DBV Technologies's total debt decreased by 15.7% year-over-year, from $7.23M to $6.1M.
What is the long-term trend for DBV Technologies's total debt?
Over 5 years (2020 to 2025), DBV Technologies's total debt has grown at a -14.5% compound annual growth rate (CAGR), from $14.21M to $6.5M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.